Characteristics of rifampin-resistant variants obtained from clinical isolates of Staphylococcus aureus.
about
Biological cost of rifampin resistance from the perspective of Staphylococcus aureusTitanium-tethered vancomycin prevents resistance to rifampicin in Staphylococcus aureus in vitroProtective properties of rifampin-resistant rough mutants of Brucella melitensisVancomycin displays time-dependent eradication of mature Staphylococcus aureus biofilms.Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections.Potential mechanisms of attenuation for rifampicin-passaged strains of Flavobacterium psychrophilum.Antimicrobial resistance of Staphylococcus aureus: genetic basis.Rifampicin-resistant Mycobacterium leprae in an elderly leprosy patient in the people's Republic of China.Brucellosis in domestic water buffalo (Bubalus bubalis) of Trinidad and Tobago with comparative epidemiology to cattle.Isolation of rifampin-resistant mutants of Listeria monocytogenes and their characterization by rpoB gene sequencing, temperature sensitivity for growth, and interaction with an epithelial cell line.Rifampin resistance of Legionella pneumophila is not increased during therapy for experimental Legionnaires disease: study of rifampin resistance using a guinea pig model of Legionnaires disease.Treatment of severe infections caused by penicillin-resistant pneumococci. Role of third generation cephalosporins.Genetic bases of the rifampin resistance phenotype in Brucella spp.Frequency, spectrum, and nonzero fitness costs of resistance to myxopyronin in Staphylococcus aureus.Aminoglycoside-resistance mechanisms in multidrug-resistant Staphylococcus aureus clinical isolates.Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs
P2860
Q24538819-850AC35F-668D-4BB0-B0B4-3994940CBF08Q28484511-7F80640E-231A-47F6-BB5E-411DEBCF28ACQ33883263-26C967F5-B9EC-4DCB-802F-F59BE592890CQ34526414-0DF5765A-FD1E-4898-81DE-04624B4A963BQ35647232-A30D3036-0D51-4E9D-9B45-32E346975D76Q35777815-A475669D-7470-4E57-9FAA-384144347DB2Q37063182-C3ADC87A-ABB5-4F51-9C84-6F04F3B79B7DQ37124635-04670DCB-60C5-478C-A24F-B51797334C33Q37863545-D21EE0C6-55A3-4DB3-91BA-C10485DC0B22Q39451663-67E7F505-947B-499C-A71D-3635416262A8Q40085510-F3CD90BB-2009-418F-B77D-7A8E8B8900D7Q40584330-81AB19F8-E906-49D4-B976-990088833905Q40624193-54844B6B-ACE0-4569-A5C6-78C53F4EB410Q41184787-1E053167-620C-4044-9972-E1B58C76CED7Q44545131-A6C16943-88DD-4CD2-8812-504BEFEC1A2AQ58793869-8CDC303D-53C9-420C-9620-A37505A342D4
P2860
Characteristics of rifampin-resistant variants obtained from clinical isolates of Staphylococcus aureus.
description
1981 nî lūn-bûn
@nan
1981 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Characteristics of rifampin-re ...... ates of Staphylococcus aureus.
@ast
Characteristics of rifampin-re ...... ates of Staphylococcus aureus.
@en
type
label
Characteristics of rifampin-re ...... ates of Staphylococcus aureus.
@ast
Characteristics of rifampin-re ...... ates of Staphylococcus aureus.
@en
prefLabel
Characteristics of rifampin-re ...... ates of Staphylococcus aureus.
@ast
Characteristics of rifampin-re ...... ates of Staphylococcus aureus.
@en
P2860
P356
P1476
Characteristics of rifampin-re ...... ates of Staphylococcus aureus.
@en
P2093
Mandell GL
Moorman DR
P2860
P304
P356
10.1128/AAC.20.6.709
P407
P577
1981-12-01T00:00:00Z